A form of lung cancer, which is found in about 10%–15% of Western patients and 40%–50% of Asian patients, is driven by a ...

CDK4/6 inhibitors — possible colitis: Ibrance, Kisqali (including the Kisqali Femara Co-Pack) and Verzenio. These pills are ...

Wall Street analysts believe Verastem’s drug to now be “competitive” in what’s quickly become one of the most active and ...

Targeted gene therapies are highly effective at stopping cancers, but the very abundance of the treatments, plus cost and sluggish change, are hindering access.

Thyme Care, the nationally recognized oncology company, and Texas Oncology, the nation's leading cancer care organization, today announced new data showing that weight-based dosing of pembrolizumab, ...

Anktiva’s newfound FDA label expansion comes as the agency deems cases of CIS and high-grade papillary only NMIBC clinically similar.

Researchers are asking why patients, like former Senator Ben Sasse, inevitably develop resistance to the drug daraxonrasib.

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. A new targeted treatment for pancreatic cancer has been approved by the FDA after impressive ...

When an ad for a new cancer drug pops up in your newsfeed, it might look like an overnight success. But even developing a ...

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. Photo Illustration of the new Wegovy semaglutide tablets with injectable prescription weight ...

By Siddhi Mahatole Oct 12 (Reuters) - Bristol Myers Squibb said on Monday its experimental radiopharmaceutical cancer therapy ...

NeOnc Technologies Holdings (NASDAQ: NTHI) made a powerful leadership move at a pivotal moment in its brain-cancer drug development strategy. The appointment of Ali Alabedin, Head of Islamic Banking ...